Cargando…
AJP001, a novel helper T‐cell epitope, induces a humoral immune response with activation of innate immunity when included in a peptide vaccine
Vaccine design requires well‐tailored formulations including a T‐cell epitope and adjuvants. We identified a novel cationic peptide, AJP001, which possesses a strong affinity for murine MHC class II alleles (H2‐IE(d) and H2‐IA(d)) and low affinity for H2‐IA(b). We designed an AJP001 and epitope pept...
Autores principales: | Tenma, Akiko, Nakagami, Hironori, Tomioka, Hideki, Sakaguchi, Makoto, Ide, Ryoko, Koriyama, Hiroshi, Hayashi, Hiroki, Shimamura, Munehisa, Rakugi, Hiromi, Morishita, Ryuichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996369/ https://www.ncbi.nlm.nih.gov/pubmed/32123820 http://dx.doi.org/10.1096/fba.2019-00056 |
Ejemplares similares
-
Development of an IL-17A DNA Vaccine to Treat Systemic Lupus Erythematosus in Mice
por: Koriyama, Hiroshi, et al.
Publicado: (2020) -
The CD153 vaccine is a senotherapeutic option for preventing the accumulation of senescent T cells in mice
por: Yoshida, Shota, et al.
Publicado: (2020) -
A novel angiotensin II peptide vaccine without an adjuvant in mice
por: Nakamaru, Ryo, et al.
Publicado: (2021) -
Therapeutic vaccine for chronic diseases after the COVID-19 Era
por: Nakagami, Hironori, et al.
Publicado: (2021) -
Gene Therapy and Cell-Based Therapies for Therapeutic Angiogenesis in Peripheral Artery Disease
por: Shimamura, Munehisa, et al.
Publicado: (2013)